Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Revenue projections:

Revenue projections for MAXHEALTH
Revenue projections for MAXHEALTH

MAXHEALTH is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 56.869095
debtToEquity 20.095000
earningsGrowth -0.178000
revenueGrowth 0.400000
grossMargins 0.623410
operatingMargins 0.214950
trailingEps 10.330000
forwardEps 0.000000

MAXHEALTH's forward PE is too high, signaling potential overvaluation. This could cap future price increases and trigger a correction. Investors should carefully analyze this metric along with other fundamental indicators before making investment decisions.
Max Healthcare Institute Limited's Debt-to-Equity ratio is low, indicating the company is not over-leveraged. This suggests a prudent approach to financing, with minimal dependence on debt, reducing the financial risk associated with high leverage, and signaling a stable financial outlook.
MAXHEALTH's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.

Price projections:

Price projections for MAXHEALTH
Price projections for MAXHEALTH

Over time, price projections for MAXHEALTH have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for MAXHEALTH's continued growth.

Recommendation changes over time:

Recommendations trend for MAXHEALTH
Recommendations trend for MAXHEALTH


The recent buy bias from analysts suggests MAXHEALTH is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, MAXHEALTH appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.